Scholar Rock

Anatomical model of human arm and torso showing muscle
Pharma

Scholar Rock scores its first FDA approval for SMA treatment

The treatment, which is set to “ship in the coming days” is projected to cost $310,000 annually.
Donavyn Coffey Sep 14, 2026 10:37am
scissor cutting rope

Novo’s Catalent plant ditched in FDA refiling of SMA drug

Aug 10, 2026 10:06am
FDA

Novo plant issues may mean delays for Regeneron, Scholar Rock

Oct 13, 2025 3:48pm
red light stoplight

Issues at Novo site delay Scholar Rock's bid for SMA approval

Sep 23, 2025 9:19am